Skip to main content
. 2020 May 29;245(14):1260–1267. doi: 10.1177/1535370220929621

Table 2.

Insulin and insulin resistance indices in investigated groups.

All elderly participants free of diabetesn = 86 ElderlyInsS groupn = 35 ElderlyInsR groupn = 51 Significant difference
Ins 0ʹ [mU/L] 31.6 (17.3–36.2) 15.8 (14.0–22.5) 34.6 (31.9–40.8) 0.000000…
Ins 120ʹ [mU/L] 67.1 (33.6–118.7) 52.2 (23.1–125.3) 81.7 (48.7–112.2) NS
Mean Ins [mU/L] 46.6 (31.7–71.4) 37.1 (22.3–70.0) 54.6 (39.1–72.9) 0.014
IR 0.31 (0.17–0.35) 0.16 (0.12–0.22) 0.35 (0.32–0.39) by deff.
HOMA-IR 7.38 (4.44–9.95) 4.34 (3.02–5.77) 8.46 (7.23–11.22) 0.000000…
QUICKI 0.45 (0.42–0.50) 0.50 (0.47–0.55) 0.44 (0.42–0.45) 0.000000…
Matsuda 2.64 (1.90–3.68) 3.68 (3.18–5.65) 2.29 (1.73–2.81) 0.000073

Note: Data are presented as median with interquartile range (lower–upper).

InsS: insulin sensitive group; InsR: insulin resistant group; NS: not significant; Ins 0ʹ: fasting insulin; Ins 120ʹ: insulin concentration at 120 min during oral glucose tolerance test; Mean Ins: mean insulin concentration from the Oral Glucose Tolerance Test; HOMA-IR: homeostasis model assessment for insulin resistance; QUICKI: quantitative insulin sensitivity check index; Matsuda: the insulin sensitivity index obtained from an oral glucose tolerance test; by deff: by definition.